On March 19, 2024 Dechra Pharmaceuticals had a market cap of HK$43.50 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | HK$43.45 B | -0.68% |
2023 | HK$43.75 B | 55.11% |
2022 | HK$28.20 B | -53.56% |
2021 | HK$60.73 B | 54.06% |
2020 | HK$39.42 B | 29.41% |
2019 | HK$30.46 B | 44.37% |
2018 | HK$21.10 B | 2.55% |
2017 | HK$20.57 B | 72.54% |
2016 | HK$11.92 B | 7.84% |
2015 | HK$11.05 B | 24.48% |
2014 | HK$8.88 B | 13.25% |
2013 | HK$7.84 B | 19.72% |
2012 | HK$6.55 B | 57.86% |
2011 | HK$4.15 B | 4.3% |
2010 | HK$3.97 B | -2.34% |
2009 | HK$4.07 B | 49.3% |
2008 | HK$2.72 B | -9.43% |
2007 | HK$3.01 B | 42.61% |
2006 | HK$2.11 B | 18.06% |
2005 | HK$1.79 B | 28.88% |
2004 | HK$1.38 B | 57.84% |
2003 | HK$0.87 B | 55.39% |
2002 | HK$0.56 B | -30.63% |
2001 | HK$0.81 B |